Israeli researchers test experimental diabetes treatment

A research team from Israel's Bar-Ilan University has announced the results of a scientific trial on mice with a condition mimicking Latent Autoimmune Diabetes in Adults, known as "LADA" or type 1.5 diabetes, showing remarkable improvement in a group of the animals that underwent the treatment.

According to a report published by the "Times of Israel" on Saturday, November 14, 2026, coinciding with World Diabetes Day, scientists used an experimental combination of three drug compounds: "GABA," "Sitagliptin," and "Omeprazole." They found that blood sugar levels returned to the normal range in about 30 percent of the treated mice.

The research focuses on trying to understand why some cases respond to treatment while others do not, which may help in the future to develop therapeutic approaches more tailored to the biological characteristics of each patient.

However, the results do not mean a cure has been discovered for humans, as the experiment was conducted on laboratory animals that mimic the disease, and further studies are still needed to prove safety and efficacy in humans before this approach can be applied therapeutically.